# 2026-02505: Findings of Research Misconduct

2026-02505, Findings of Research Misconduct, is a Federal Register notice from Health and Human Services Department published 2026-02-09, effective 2026-01-11 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-02505
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-02505
- Title: Findings of Research Misconduct
- Type: Notice
- Agencies: Health and Human Services Department
- Citation: 91 FR 5774
- Published: 2026-02-09
- Effective: 2026-01-11
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

Dr. Daniel Andrade from the University of Oklahoma was caught faking data in two important research grant applications, which could have affected millions in public health funding. Because of this, he’ll be supervised for three years to keep things honest. This action protects the integrity of research and signals serious consequences for cheating in science.

## Abstract

Findings of research misconduct have been made against Daniel Andrade, Ph.D., former Assistant Professor of Research, Department of Obstetrics and Gynecology and Stephenson Cancer Center, University of Oklahoma Health Science Center. Dr. Andrade engaged in research misconduct under 42 CFR part 93 in research included in two (2) grant applications submitted for U.S. Public Health Service (PHS) funds, specifically DP2 OD030789-01 submitted to the Office of the Director (OD), National Institutes of Health (NIH), and R21 CA253956-01 submitted to the National Cancer Institute (NCI), NIH. Administrative actions, including supervision for a period of three (3) years, were implemented and are detailed below.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20447](https://policyrisk.com/federal-register/2026-20447): Transparency in Coverage, 2026-10-06
- [2026-20281](https://policyrisk.com/federal-register/2026-20281): Global Benchmark for Efficient Drug Pricing (GLOBE) Model, 2026-10-02
- [2026-20131](https://policyrisk.com/federal-register/2026-20131): Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality…, 2026-10-01
- [2026-19959](https://policyrisk.com/federal-register/2026-19959): Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Prog…, 2026-09-30
- [2026-20067](https://policyrisk.com/federal-register/2026-20067): Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements; Correction, 2026-09-30
- [2026-19946](https://policyrisk.com/federal-register/2026-19946): Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospectiv…, 2026-09-29

## Sources
- [2026-02505 on federalregister.gov](https://www.federalregister.gov/documents/2026/02/09/2026-02505/findings-of-research-misconduct)
- [2026-02505 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-02-09/pdf/2026-02505.pdf)

## Related
- [Previous: 2026-02504, Information Collection Being Reviewed by the Federal Communications Commission…](https://policyrisk.com/federal-register/2026-02504)
- [Next: 2026-02506, Information Collection Being Submitted for Review and Approval to Office of Man…](https://policyrisk.com/federal-register/2026-02506)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-02505 (as of 2026-06-08).